Critical insights into why airborne viruses lose their infectivity have been unc...
Introducing widespread screening of newborns for a deadly disease called severe ...
AstraZeneca is partnering up with a self-identified “young” Chinese company to c...
Aldeyra Therapeutics has just shared results for its phase 3 trial, the INVIGORA...
AbbVie’s Skyrizi has posted another victory in a maintenance trial after complet...
BAT2206 received approval as a monotherapy or along with methotrexate to treat a...
The deal will add Surface Oncology’s clinical stage assets, SRF388 and SFR114, t...
The partnership will focus on selected targets from Cholesgen's early stage port...
Rosemont is targeting the single-use sachet market, shaping its decision to acqu...
The FDA extends the review period for GSK’s Sierra Oncology myelofibrosis drug m...
Medivir has already received patents for Fostrox in the EU, Japan, the US and a ...
Laurus Labs will establish a GMP facility at IIT Kanpur’s Techno Park facility.
For clinical trials operating across different counties, challenges with regulat...
In the latest edition of STAT's Health Tech newsletter: a chatbot that's cautiou...
An additional FDA hold has been placed on Mersana Therapeutics in connection wit...
The company hopes to work with other partners to bring Utidelone to market.
